These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 6116636)

  • 21. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
    Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
    Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
    Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
    Cavanagh RL; Usakewicz JJ; Buyniski JP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antagonism of vasodepressor and gastric secretory responses to histamine by the H2-receptor antagonists, ranitidine and cimetidine, in the anaesthetized dog.
    Daly MJ; Humphray JM; Stables R
    Br J Pharmacol; 1981 Jan; 72(1):55-60. PubMed ID: 6112035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the effects of ranitidine, cimetidine and placebo on the 24 hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer.
    Walt RP; Male PJ; Rawlings J; Hunt RH; Milton-Thompson GJ; Misiewicz JJ
    Gut; 1981 Jan; 22(1):49-54. PubMed ID: 6109686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of ranitidine, a new histamine H2-receptor antagonist, on secretagogue-stimulated gastric secretion in rats: comparison with cimetidine (author's transl)].
    Okabe S; Kawakami M
    Nihon Yakurigaku Zasshi; 1981 Aug; 78(2):57-62. PubMed ID: 6119281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ranitidine inhibition of gastric secretion stimulated by pentagastrin. Results in 30 cases of duodenal ulcer].
    Toulet J; Pagniez R; Viteau JM; Rousselet J; Bosc F; Vienne JL
    Ann Gastroenterol Hepatol (Paris); 1986; 22(1):9-14. PubMed ID: 3083759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of ranitidine, a new H2-antagonist, on gastric and pancreatic secretion in duodenal ulcer patients.
    Konturek SJ; Obtułowicz W; Kwiecień N; Sito E; Oleksy J; Miszczuk-Jamska B
    Dig Dis Sci; 1980 Oct; 25(10):737-43. PubMed ID: 6107221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of ranitidine on gastric mucus, pepsin and hydrochloric acid secretion in patients with duodenal ulcer.
    Gabryelewicz A; Sarosiek J; Laszewicz W
    Acta Med Pol; 1981; 22(4):335-9. PubMed ID: 6128866
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacology and clinical efficacy of ranitidine, a new H2-receptor antagonist.
    Helman CA; Tim LO
    Pharmacotherapy; 1983; 3(4):185-92. PubMed ID: 6136952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of BMY-25368, a potent and long-acting histamine H2-receptor antagonist, on gastric secretion and aspirin-induced gastric lesions in the dog.
    Cavanagh RL; Buyniski JP
    Aliment Pharmacol Ther; 1989 Jun; 3(3):299-313. PubMed ID: 2577694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of gastric acid secretion in the dog by the H2-receptor antagonists, ranitidine, cimetidine, and metiamide.
    Daly MJ; Humphray JM; Stables R
    Gut; 1980 May; 21(5):408-12. PubMed ID: 6107261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of H2-receptor blockade by ranitidine on ulcer healing and gastric acid secretion in patients with gastric and duodenal ulcers.
    Forssell H; Koch G
    Eur J Clin Pharmacol; 1983; 25(2):195-8. PubMed ID: 6313376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of an oral morning dose of nizatidine and ranitidine on gastric acid secretion in duodenal ulcer patients.
    Lazzaroni M; Bianchi Porro G
    Hepatogastroenterology; 1989 Dec; 36(6):490-3. PubMed ID: 2575571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical comparison of cimetidine and ranitidine.
    Brater DC; Peters MN; Eshelman FN; Richardson CT
    Clin Pharmacol Ther; 1982 Oct; 32(4):484-9. PubMed ID: 6288312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacology of JB-9315, a new selective histamine H2-receptor antagonist.
    Palacios B; Montero MJ; Sevilla MA; San Román L
    Gen Pharmacol; 1998 Feb; 30(2):181-9. PubMed ID: 9502172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long term effects of H2-receptor antagonists (cimetidine and ranitidine) on the human gastric and duodenal mucosa.
    Ribet A; Balas D; Bastie MJ; Senegas-Balas F; Escourrou J; Bommelaer G; Pradayrol L
    Scand J Gastroenterol Suppl; 1981; 70():155-74. PubMed ID: 6118944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of inhibitors of acid secretion in patients with duodenal ulcer. Comparative study of cimetidine, ranitidine and pirenzepine].
    Espinoza M; Csendes A; Medina LA; Fuster F; Braghetto I; Encina J
    Rev Med Chil; 1984 Nov; 112(11):1085-9. PubMed ID: 6152639
    [No Abstract]   [Full Text] [Related]  

  • 39. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
    Hentschel E
    Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397
    [No Abstract]   [Full Text] [Related]  

  • 40. The influence of various secretory inhibitors on peptic activity.
    Gabryelewicz A; Laszewicz W; Sarosiek J
    Scand J Gastroenterol Suppl; 1980; 66():79-85. PubMed ID: 6264587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.